Comparison of Cerebral Blood Volume and Vascular Permeability from Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging with Glioma Grade

References

1. ↵
   Daumas-Duport C, Scheithauer B, O’Fallon J, Kelly P. Grading of astrocytomas: a simple and reproducible method. Cancer 1988;62:2152–2165

   CrossRefPubMedWeb of Science
2. ↵
   Christoforidis GA, Bourekas EC, Baujan M, et al. High resolution MRI of the deep brain vascular anatomy at 8 tesla: susceptibility-based enhancement of the venous structures. J Comput Assist Tomogr 1999;23:857–866

   CrossRefPubMedWeb of Science
3. ↵
   Christoforidis GA, Grecula JC, Newton HB, et al. Visualization of microvascularity in glioblastoma multiforme with 8-T high-spatial-resolution MR imaging. AJNR Am J Neuroradiol 2002;23:1553–1556

   Abstract/FREE Full Text
4. ↵
   Burger P. Malignant astrocytic neoplasms: classification, pathology, anatomy, and response to therapy. Semin Oncol 1986;13:16–20

   PubMed
5. ↵
   Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51

   PubMedWeb of Science
6. Bruening R, Kwong KK, Vevea MJ, et al. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. AJNR Am J Neuroradiol 1996;17:831–840

   Abstract
7. Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171:1479–1486

   CrossRefPubMedWeb of Science
8. Sugahara T, Korogi Y, Shigematsu Y, et al. Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors. Top Magn Reson Imaging 1999;10:114–124

   PubMed
9. Wong ET, Jackson EF, Hess KR, et al. Correlation between dynamic MRI and outcome in patients with malignant gliomas. Neurology 1998;50:777–781

   Abstract/FREE Full Text
10. Wong JC, Provenzale JM, Petrella JR. Perfusion MR imaging of brain neoplasms. AJR Am J Roentgenol 2000;174:1147–1157

    PubMed
11. ↵
    Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–798

    CrossRefPubMedWeb of Science
12. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility- weighted echo-planar perfusion MR imaging. Radiology 2002;223:11–29

    CrossRefPubMedWeb of Science
13. Lev MH, Rosen BR. Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am 1999;9:309–331

    PubMedWeb of Science
14. Shin JH, Lee HK, Kwun BD, et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 2002;179:783–789

    CrossRefPubMed
15. ↵
    Petrella JR, Provenzale JM. MR perfusion imaging of the brain: techniques and applications. AJR Am J Roentgenol 2000;175:207–219

    CrossRefPubMedWeb of Science
16. ↵
    Roberts HC, Roberts TP, Ley S, Dillon WP, Brasch RC. Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading. Acad Radiol 2002;9(Suppl 1):S151–S155
17. ↵
    Provenzale JM, Wang GR, Brenner T, Petrella JR, Sorensen AG. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002;178:711–716

    CrossRefPubMedWeb of Science
18. ↵
    Uematsu H, Maeda M, Sadato N, et al. Vascular permeability: quantitative measurement with double-echo dynamic MR imaging–theory and clinical application. Radiology 2000;214:912–917

    PubMed
19. ↵
    Roberts HC, Roberts TPL, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000;21:891–899

    Abstract/FREE Full Text
20. ↵
    Marzola P, Farace P, Calderan L, et al. In vivo mapping of fractional plasma volume (fpv) and endothelial transfer coefficient (Kps) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure. Int J Cancer 2003;104:462–468

    CrossRefPubMedWeb of Science
21. ↵
    Kiessling F, Krix M, Heilmann M, et al. Comparing dynamic parameters of tumor vascularization in nude mice revealed by magnetic resonance imaging and contrast-enhanced intermittent power Doppler sonography. Invest Radiol 2003;38:516–524

    CrossRefPubMedWeb of Science
22. ↵
    Bogin L, Margalit R, Mispelter J, Degani H. Parametric imaging of tumor perfusion using flow- and permeability-limited tracers. J Magn Reson Imaging 2002;16:289–299

    CrossRefPubMed
23. ↵
    Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Res Med 1990;14:249–265

    PubMedWeb of Science
24. ↵
    Johnson G, Wetzel SG, Cha S, Bobb J, Tofts PS. Measuring blood volume and vascular transfer constant from dynamic, T2*-weighted contrast-enhanced MRI. Magn Res Med 2004;51: in press
25. ↵
    McDonald DM, Blank P. Significance of blood vessel leakiness in cancer. Cancer Res 2002;62:5381–5385

    Abstract/FREE Full Text
26. ↵
    McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med 2003;9:713–725

    CrossRefPubMedWeb of Science
27. ↵
    Bhujwalla ZM, Artemov D, Natarajan K, Solaiyappan M, Kollars P, Kristjansen PEG. Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after Treatment with antiangiogenic agent TNP-470. Clin Cancer Res 2003;9:355–362

    Abstract/FREE Full Text
28. ↵
    Robinson SP, McIntyre DJ, Checkley D, Tessier JJ, Howe FA, Griffith JR. Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. Br J Cancer 2003;88:1592–1597

    CrossRefPubMedWeb of Science
29. ↵
    Ringertz J. Grading of gliomas. Acta Pathol Microbiol Scand 1950;27:51–64

    PubMedWeb of Science
30. ↵
    Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002;224:797–803

    CrossRefPubMedWeb of Science
31. ↵
    Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging: fundamental concepts. Magn Res Med 1991;17:357–367

    CrossRefPubMedWeb of Science
32. ↵
    Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223–232

    CrossRefPubMedWeb of Science
33. ↵
    Leenders KL, Perani D, Lammertsma AA, et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain 1990;113(pt 1):27–47
34. ↵
    Vajkoczy P, Menger MD. Vascular microenvironment in gliomas. J Neurooncol 2000;50:99–108

    CrossRefPubMed
35. ↵
    Sorensen AG, Reimer P. Cerebral MR Perfusion Imaging: Principles and Current Applications. New York: Thieme,2000
36. ↵
    Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 1998;49:436–440

    CrossRefPubMedWeb of Science
37. ↵
    Rydland J, BjOrnerud A, Haugen O, et al. New intravascular contrast agent applied to dynamic contrast enhanced MR imaging of human Breast cancer. Acta Radiologica 2003;44:275–283

    CrossRefPubMedWeb of Science
38. ↵
    Cha S, Johnson G, Wadghiri YZ, et al. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: Correlation with histopathology. Magn Reson Med 2003;49:848–855

    CrossRefPubMedWeb of Science
39. ↵
    Degani H, Chetrit-Dadiani M, Bogin L, Furman-Haran E. Magnetic resonance imaging of tumor vasculature. Thromb Haemost 2003;89:23–33
40. ↵
    Cha S, Lu S, Johnson G, Knopp EA. Dynamic susceptibility contrast MR imaging: correlation of signal intensity changes with cerebral blood volume measurements. J Magn Reson Imaging 2000;11:114–119

    CrossRefPubMed
41. ↵
    Li KL, Zhu XP, Checkley DR, et al. Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data. Br J Radiol 2003;76:39–51

    Abstract/FREE Full Text
42. ↵
    Yang S, Law M, Zagzag D, et al. Dynamic contrast enhanced perfusion MRI measurements of endothelial permeability: differentiation Between atypical and typical meningiomas. AJNR Am J Neuroradiol 2003;24:1554–1559

    Abstract/FREE Full Text
43. ↵
    Parker GJ, Suckling J, Tanner SF, et al. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging 1997;7:564–574

    PubMed
44. ↵
    Wetzel SG, Cha S, Law M, et al. Preoperative assessment of intracranial tumors with perfusion MR and a volumetric interpolated examination: a comparative study with DSA. AJNR Am J Neuroradiol 2002;23:1767–1774

    Abstract/FREE Full Text
45. ↵
    Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity and predictive value of perfusion MRI and proton spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003 :24:1989–1998

    Abstract/FREE Full Text